PUBLISHER: Grand View Research | PRODUCT CODE: 1750654
PUBLISHER: Grand View Research | PRODUCT CODE: 1750654
U.S. Cardiovascular Health Supplements Market Size, Share & Trends Analysis Report By Ingredient, By Form, By, Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
U.S. Cardiovascular Health Supplements Market Growth & Trends:
The U.S. cardiovascular health supplements market size is anticipated to reach USD 3.27 billion by 2030 and is projected to grow at a CAGR of 7.61% during the forecast period, according to a new report by Grand View Research, Inc. This robust growth is largely attributed to the increasing incidence of cardiovascular diseases, rising health consciousness, and the aging population's growing demand for preventive healthcare. As heart-related conditions remain a leading cause of mortality in the U.S., consumers are increasingly seeking non-prescription, natural solutions to manage and reduce associated risks.
Key ingredients such as omega-3 fatty acids, CoQ10, magnesium, and plant sterols continue to dominate the market due to their proven benefits in supporting heart health. In addition, advancements in supplement delivery systems-such as softgels, capsules, and extended-release tablets-are enhancing bioavailability and consumer adherence. The shift toward clean-label, plant-based, and clinically supported formulations is also influencing purchasing decisions, especially among health-conscious and senior demographics seeking long-term wellness solutions. Thereby propelling the demand for cardiovascular health supplements in the U.S. over the forecast period.
The COVID-19 pandemic substantially boosted the demand for cardiovascular health supplements in the U.S. market, driven by heightened health awareness, increased focus on immunity and chronic disease prevention, and a shift toward proactive wellness. Consumers became more conscious of underlying health conditions, including heart health, leading to a surge in demand for supplements containing omega-3s, CoQ10, and other heart-supportive ingredients.
However, despite rising demand, the U.S. cardiovascular health supplements industry faces challenges such as limited clinical validation, regulatory restrictions on health claims, and inconsistent product quality across brands. These factors contribute to consumer skepticism and reduce adoption among healthcare professionals. In addition, high product costs and lack of insurance coverage further limit accessibility, collectively hampering the growth of the market.
U.S. Cardiovascular Health Supplements Market Report Highlights:
- The omega fatty acids held the largest market share of 27.36% in 2024. This is attributed to their well-documented benefits in reducing cardiovascular risk factors such as high cholesterol and blood pressure. However, herbs & botanicals are anticipated to grow at the fastest CAGR over the forecast period.
- The natural supplements segment dominated the market in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This is driven by increasing consumer preference for clean-label, plant-based, and minimally processed products with perceived safety and long-term health benefits.
- The softgels held the largest market share in 2024. This is driven by their convenient dosage form and consumer preference for easy-to-consume supplements. However, capsules are anticipated to grow at the fastest CAGR over the forecast period.
- The offline distribution channel segment dominated the market with the largest revenue share in 2024. However, the online segment is expected to grow at the fastest CAGR over the forecast period.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Ingredient Segment
- 1.2.2. Type Segment
- 1.2.3. Form Segment
- 1.2.4. Distribution Channel Segment
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Research
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising prevalence of cardiovascular diseases
- 3.2.1.2. Aging population
- 3.2.2. Market restraint analysis
- 3.2.2.1. High competition and market saturation
- 3.2.1. Market driver analysis
- 3.3. U.S. Cardiovascular Health Supplements Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Cardiovascular Health Supplement Market: Ingredient Estimates & Trend Analysis
- 4.1. Ingredient Segment Dashboard
- 4.2. U.S. Cardiovascular Health Supplement Market Ingredient Movement Analysis
- 4.3. U.S. Cardiovascular Health Supplement Market Size & Trend Analysis, by Ingredient, 2018 to 2030 (USD Million)
- 4.4. Vitamins & Minerals
- 4.4.1. Vitamins & Minerals Market, 2018 - 2030 (USD Million)
- 4.5. Herbs & Botanicals
- 4.5.1. Herbs & Botanicals Market, 2018 - 2030 (USD Million)
- 4.6. Omega Fatty Acids
- 4.6.1. Omega Fatty Acids Market, 2018 - 2030 (USD Million)
- 4.7. Coenzyme Q10 (CoQ10)
- 4.7.1. Coenzyme Q10 (CoQ10) Market, 2018 - 2030 (USD Million)
- 4.8. Others
- 4.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. U.S. Cardiovascular Health Supplement Market: Type Estimates & Trend Analysis
- 5.1. Type Segment Dashboard
- 5.2. U.S. Cardiovascular Health Supplement Market Type Movement Analysis
- 5.3. U.S. Cardiovascular Health Supplement Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 5.4. Natural Supplements
- 5.4.1. Natural Supplements Market, 2018 - 2030 (USD Million)
- 5.5. Synthetic Supplements
- 5.5.1. Synthetic Supplements Market, 2018 - 2030 (USD Million)
Chapter 6. U.S. Cardiovascular Health Supplements Market: Form Estimates & Trend Analysis
- 6.1. Form Segment Dashboard
- 6.2. U.S. Cardiovascular Health Supplements Market Form Movement Analysis
- 6.3. U.S. Cardiovascular Health Supplements Market Size & Trend Analysis, by Form, 2018 to 2030 (USD Million)
- 6.4. Liquid
- 6.4.1. Liquid Market, 2018 - 2030 (USD Million)
- 6.5. Tablet
- 6.5.1. Tablet Market, 2018 - 2030 (USD Million)
- 6.6. Capsules
- 6.6.1. Capsules Market, 2018 - 2030 (USD Million)
- 6.7. Softgels
- 6.7.1. Softgels Market, 2018 - 2030 (USD Million)
- 6.8. Powder
- 6.8.1. Powder Market, 2018 - 2030 (USD Million)
- 6.9. Others
- 6.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. U.S. Cardiovascular Health Supplements Market: Distribution Channel Estimates & Trend Analysis
- 7.1. Distribution Channel Segment Dashboard
- 7.2. U.S. Cardiovascular Health Supplements Market Distribution Channel Movement Analysis
- 7.3. U.S. Cardiovascular Health Supplements Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
- 7.4. Offline
- 7.4.1. Offline Market, 2018 - 2030 (USD Million)
- 7.5. Online
- 7.5.1. Online Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Profiles/Listing
- 8.3.1. NOW Foods
- 8.3.1.1. Overview
- 8.3.1.2. Financial Performance
- 8.3.1.3. Product Benchmarking
- 8.3.1.4. Strategic Initiatives
- 8.3.2. Bright Lifecare Private Ltd (Truebasics.com)
- 8.3.2.1. Overview
- 8.3.2.2. Financial Performance
- 8.3.2.3. Product Benchmarking
- 8.3.2.4. Strategic Initiatives
- 8.3.3. Natural Organics, Inc.
- 8.3.3.1. Overview
- 8.3.3.2. Financial Performance
- 8.3.3.3. Product Benchmarking
- 8.3.3.4. Strategic Initiatives
- 8.3.4. DaVinci Laboratories of Vermont
- 8.3.4.1. Overview
- 8.3.4.2. Financial Performance
- 8.3.4.3. Product Benchmarking
- 8.3.4.4. Strategic Initiatives
- 8.3.5. Nordic Naturals
- 8.3.5.1. Overview
- 8.3.5.2. Financial Performance
- 8.3.5.3. Product Benchmarking
- 8.3.5.4. Strategic Initiatives
- 8.3.6. Thorne.
- 8.3.6.1. Overview
- 8.3.6.2. Financial Performance
- 8.3.6.3. Product Benchmarking
- 8.3.6.4. Strategic Initiatives
- 8.3.7. Nestle Health Science (Pure Encapsulations, LLC.)
- 8.3.7.1. Overview
- 8.3.7.2. Financial Performance
- 8.3.7.3. Product Benchmarking
- 8.3.7.4. Strategic Initiatives
- 8.3.8. Amway Corp.
- 8.3.8.1. Overview
- 8.3.8.2. Financial Performance
- 8.3.8.3. Product Benchmarking
- 8.3.8.4. Strategic Initiatives
- 8.3.9. InVite Health
- 8.3.9.1. Overview
- 8.3.9.2. Financial Performance
- 8.3.9.3. Product Benchmarking
- 8.3.9.4. Strategic Initiatives
- 8.3.10. GNC Holdings, LLC
- 8.3.10.1. Overview
- 8.3.10.2. Financial Performance
- 8.3.10.3. Product Benchmarking
- 8.3.10.4. Strategic Initiatives
- 8.3.1. NOW Foods
List of Tables
- Table 1. U.S. cardiovascular health supplements market estimates & forecasts
- Table 2. U.S. cardiovascular health supplements market estimates & forecasts, by ingredient, 2018 - 2030 (USD Million)
- Table 3. U.S. cardiovascular health supplements market estimates & forecasts, by type, 2018 - 2030 (USD Million)
- Table 4. U.S. cardiovascular health supplements market estimates & forecasts, by form, 2018 - 2030 (USD Million)
- Table 5. U.S. cardiovascular health supplements market estimates & forecasts, by distribution channel, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market snapshot
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Market trends & outlook
- Fig. 7 Market segmentation & scope
- Fig. 8 Market driver relevance analysis (Current & future impact)
- Fig. 9 Market restraint relevance analysis (Current & future impact)
- Fig. 10 PESTLE Analysis
- Fig. 11 Porter's Five Forces Analysis
- Fig. 12 Strategy framework
- Fig. 13 Participant categorization
- Fig. 14 U.S. cardiovascular health supplements market: Ingredient outlook key takeaways
- Fig. 15 U.S. cardiovascular health supplements market: Ingredient movement analysis
- Fig. 16 Vitamins & minerals market, 2018 - 2030 (USD Million)
- Fig. 17 Herbs & botanicals market, 2018 - 2030 (USD Million)
- Fig. 18 Omega fatty acids market, 2018 - 2030 (USD Million)
- Fig. 19 Coenzyme Q10 (CoQ10) market, 2018 - 2030 (USD Million)
- Fig. 20 Others market, 2018 - 2030 (USD Million)
- Fig. 21 U.S. cardiovascular health supplements market: Type outlook key takeaways
- Fig. 22 U.S. cardiovascular health supplements market: Type movement analysis
- Fig. 23 Natural supplements market, 2018 - 2030 (USD Million)
- Fig. 24 Synthetic supplements market, 2018 - 2030 (USD Million)
- Fig. 25 U.S. cardiovascular health supplements market: Form outlook key takeaways
- Fig. 26 U.S. cardiovascular health supplements market: Form movement analysis
- Fig. 27 Liquid market, 2018 - 2030 (USD Million)
- Fig. 28 Capsules market, 2018 - 2030 (USD Million)
- Fig. 29 Tablets market, 2018 - 2030 (USD Million)
- Fig. 30 Softgels market, 2018 - 2030 (USD Million)
- Fig. 31 Powder market, 2018 - 2030 (USD Million)
- Fig. 32 Others market, 2018 - 2030 (USD Million)
- Fig. 33 U.S. cardiovascular health supplements market: End use outlook key takeaways
- Fig. 34 U.S. cardiovascular health supplements market: End use movement analysis
- Fig. 35 Offline market, 2018 - 2030 (USD Million)
- Fig. 36 Online market, 2018 - 2030 (USD Million)
- Fig. 37 U.S. cardiovascular health supplements market, 2018 - 2030 (USD Million)
- Fig. 38 Key companies profiled
